Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 May 2019 | Story Igno van Niekerk | Photo Stephen Collett
Digital storytelling
Collaborating for the common good are from left: Willem Ellis, Karen Venter, Dr Deidre van Rooyen, Prof Hendri Kroukamp, Bishop Billyboy Ramahlele, and Dr Johan van Zyl.

Prof Hendri Kroukamp, Dean of the Faculty of Management Sciences quoted the Cat Stevens song I can’t keep it in, to capture the excitement surrounding the opening of a Digital Storytelling Lab on the Bloemfontein Campus on 10 May 2019.

After months of hard work by Dr Deidre van Rooyen, Willem Ellis, Karen Venter, as well as the staff of the University of the Free State’s (UFS) Centre for Development Support, the Common Good First lab was completed just in time for the launch attended by about 50 delegates from other South African universities, as well as private and public institutions.

Stories meet technology

In a message, from Prof Puleng LenkaBula, Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, informed the audience that the launch heralded the joining of the old world of stories with the new world of digital technology. Julie Adair, Director of Digital Collaboration at Glasgow Caledonian University, Scotland, welcomed the UFS as a partner to this international social innovation collaborative project in a video message. 

Dr Van Rooyen, the project manager for the UFS, explained how she got involved in the Common Good First project, what the benefits of digital storytelling are, as well as what opportunities the lab creates for cooperation between role players involved in social innovation projects. 

Why the Common Good First lab?

The purpose of the lab is to create a digital network to identify, showcase and connect social innovation projects in South Africa to one another and to universities around the world for research, student engagement and learning and teaching. The lab has been fitted with state-of-the-art equipment for recording and digitising the stories that result from social innovation projects.

In a live Skype session with Dr Il-Haam Petersen, Postdoctoral Research Fellow at the Human Sciences Research Council (HSRC), and some of the recent successes of the digital stories in Philippi in the Western Cape were shared.

Bishop Billyboy Ramahlele, UFS Director Community Engagement did the final honours by cutting the ribbon, declaring the lab open, and sharing the dream that the work done in this lab will contribute to positive relationships and cooperation between the university and the community, in making not only the university, but the country and the world a better place.


News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept